Page 47 - BH-3-1

Brain & Heart Depression, anxiety and blood pressure control

controlled trial. Health Sci Rep. 2021;4:e296. 50. Zakiyah N, Ter Heijne LF, Bos JH, Hak E, Postma MJ,
Schuiling-Veninga CCM. Antidepressant use during
doi: 10.1002/hsr2.296
pregnancy and the risk of developing gestational
39. Kessing LV, Rytgaard HC, Ekstrøm CT, Torp- hypertension: A retrospective cohort study. BMC Pregnancy
Pedersen C, Berk M, Gerds TA. Antihypertensive drugs and Childbirth. 2018;18:187.
risk of depression: A nationwide population-based study.
Hypertension. 2020;76:1263-1279. doi: 10.1186/s12884-018-1825-y
doi: 10.1161/HYPERTENSIONAHA.120.15605 51. Bernard N, Forest JC, Tarabulsy GM, Bujold E, Bouvier D,
Giguère Y. Use of antidepressants and anxiolytics in early
40. Ranchord AM, Spertus JA, Buchanan DM, Gosch KL, pregnancy and the risk of preeclampsia and gestational
Chan PS. Initiation of β-blocker therapy and depression after hypertension: A prospective study. BMC Pregnancy
acute myocardial infarction. Am Heart J. 2016;174:37-42. Childbirth. 2019;19:146.
doi: 10.1016/j.ahj.2015.11.018 doi: 10.1186/s12884-019-2285-8
41. Agustini B, Mohebbi M, Woods RL, et al. The association 52. Toh S, Mitchell AA, Louik C, Werler MM, Chambers CD,
of antihypertensive use and depressive symptoms in a large Hernández-Díaz S. Selective serotonin reuptake inhibitor
older population with hypertension living in Australia and use and risk of gestational hypertension. Am J Psychiatry.
the United States: A cross-sectional study. J Hum Hypertens. 2009;166:320-328.
2020;34:787-794.
doi: 10.1176/appi.ajp.2008.08060817
doi: 10.1038/s41371-020-0303-y
53. Wathra R, Mulsant BH, Thomson L, et al. Hypertension
42. Li Y, Fan Y, Sun Y, Alolga RN, Xiao P, Ma G. Antihypertensive and orthostatic hypotension with venlafaxine treatment in
drug use and the risk of depression: A systematic review and depressed older adults. J Psychopharmacol. 2020;34:1112-1118.
network meta-analysis. Front Pharmacol. 2021;12:777987.
doi: 10.1177/0269881120944154
doi: 10.3389/fphar.2021.777987
54. Park K, Kim S, Ko YJ, Park BJ. Duloxetine and cardiovascular
43. Stahl SM. Essential Psychopharmacology. Neuroscientific adverse events: A systematic review and meta-analysis.
Basis and Practical Applications. 4 ed. Cambridge: J Psychiatr Res. 2020;124:109-114.
th
Cambridge Medicine; 2013. p. 28.
doi: 10.1016/j.jpsychires.2020.02.022
44. Watts SW, Morrison SF, Davis RP, Barman SM. Serotonin and
blood pressure regulation. Pharmacol Rev. 2012;64:359-388. 55. Selke KJ, Dhar G, Cohn JM. Takotsubo cardiomyopathy
associated with titration of duloxetine. Tex Heart Inst J.
doi: 10.1124/pr.111.004697 2011;38:573-576.
45. Meier CR, Schlienger RG, Jick H. Use of selective serotonin 56. Raskin J, Wiltse CG, Dinkel JJ, Walker DJ, Desaiah D,
reuptake inhibitors and risk of developing first-time acute Katona C. Safety and tolerability of duloxetine at 60mg
myocardial infarction. Br J Clin Pharmacol. 2001;52:179-184. once daily in elderly patients with major depressive disorder.
doi: 10.1046/j.0306-5251.2001.01426.x J Clin Psychopharmacol. 2008;28:32-38.
46. Barclay TS, Lee AJ. Citalopram-associated SIADH. Ann doi: 10.1097/jcp.0b013e318160738e
Pharmacother. 2002;36:1558-1563. 57. Behlke LM, Lenze EJ, Carney RM. The cardiovascular
doi: 10.1345/aph.1C071 effects of newer antidepressants in older adults and those
with or at high risk for cardiovascular diseases. CNS Drugs.
47. Crookes DM, Demmer RT, Keyes KM, Koenen KC, Suglia SF. 2020;34:1133-1147.
Depressive symptoms, antidepressant use, and hypertension
in young adulthood. Epidemiology. 2018;29:547-555. doi: 10.1007/s40263-020-00763-z
doi: 10.1097/EDE.0000000000000840 58. Rigotti NA, Thorndike AN, Regan S, et al. Bupropion for
smokers hospitalized with acute cardiovascular disease. Am
48. Licht CM, de Geus EJ, Seldenrijk A, et al. Depression is J Med. 2006;119:1080-1087.
associated with decreased blood pressure, but antidepressant
use increases the risk for hypertension. Hypertension. doi: 10.1016/j.amjmed.2006.04.024
2009;53:631-638.
59. Hewett K, Chrzanowski W, Jokinen R, et al. Double-
doi: 10.1161/HYPERTENSIONAHA.108.126698 blind, placebo-controlled evaluation of extended- release
bupropion in elderly patients with major depressive disorder.
49. Dawood T, Schlaich M, Brown A, Lambert G. Depression J Psychopharmacol. 2010;24:521-529.
and blood pressure control: All antidepressants are not the
same. Hypertension. 2009;54:e1. doi: 10.1177/0269881108100254
doi: 10.1161/HYPERTENSIONAHA.109.133272 60. Baldwin DS, Chrones L, Florea I, et al. The safety and

Volume 3 Issue 1 (2025) 10 doi: 10.36922/bh.4923